Efficacy of N-Acetylcysteine (NAC) in Preventing COVID-19 From Progressing to Severe Disease
Status:
Completed
Trial end date:
2021-05-14
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy of N-acetylcysteine (NAC) in preventing
those with mild or moderate COVID-19 from progressing to severe disease